CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-19 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise · Employee Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2021-08-02 | MCKEON BRIAN P Director | Purchase | +10,000 | $26.43 | $264K | 10,000 |
| 2021-07-29 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Option exercise | +14,000 | $16.55 | $232K | 88,597 |
| 2021-07-29 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Sale | −14,000 | $26.00 | $364K | 74,597 |
| 2021-07-29 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Option exercise · Employee Stock Option (Right to Buy) | −14,000 | 0 | ||
| 2021-07-01 | ANSTICE DAVID W Director | Option exercise | +20,000 | $14.60 | $292K | 93,081 |
| 2021-07-01 | ANSTICE DAVID W Director | Sale | −20,000 | $24.58 | $492K | 73,081 |
| 2021-07-01 | ANSTICE DAVID W Director | Option exercise · Non Qualified Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2021-06-14 | Wysenski Nancy Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +15,677 | 15,677 | ||
| 2021-06-14 | Wysenski Nancy Director | Grant or award · Restricted Stock Unit Award | +7,585 | 7,585 | ||
| 2021-06-14 | Wilson Frank Anders Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +15,677 | 15,677 | ||
| 2021-06-14 | Wilson Frank Anders Director | Grant or award · Restricted Stock Unit Award | +7,585 | 7,585 | ||
| 2021-06-14 | snyderman nancy lynn MD Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +15,677 | 15,677 | ||
| 2021-06-14 | snyderman nancy lynn MD Director | Grant or award · Restricted Stock Unit Award | +7,585 | 7,585 |
Page 60 of 60 · 1,194 trades